Rachel E Crossland
Rachel E Crossland
Research Associate, Newcastle University
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
Prognostic significance of immunohistochemistry‐based markers and algorithms in immunochemotherapy‐treated diffuse large B cell lymphoma patients
RE Culpin, M Sieniawski, B Angus, GK Menon, SJ Proctor, P Milne, ...
Histopathology 63 (6), 788-801, 2013
512013
Evaluation of optimal extracellular vesicle small RNA isolation and qRT-PCR normalisation for serum and urine
RE Crossland, J Norden, LA Bibby, J Davis, AM Dickinson
Journal of immunological methods 429, 39-49, 2016
492016
Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma
RA Noble, N Bell, H Blair, A Sikka, H Thomas, N Phillips, S Nakjang, ...
haematologica 102 (7), 1247-1257, 2017
422017
A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines
RE Culpin, SJ Proctor, B Angus, S Crosier, JJ Anderson, T Mainou-Fowler
International journal of oncology 37 (2), 367-376, 2010
422010
MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B …
RE Culpin, M Sieniawski, SJ Proctor, G Menon, T Mainou-Fowler
Journal of clinical pathology 66 (3), 249-252, 2013
242013
Immunophenotyping of diffuse large B-cell lymphoma (DLBCL) defines multiple sub-groups of germinal centre-like tumours displaying different survival characteristics
JJ Anderson, S Fordham, L Overman, H Dignum, K Wood, SJ Proctor, ...
International journal of oncology 35 (5), 961-971, 2009
242009
Molecular Classification of MYC-Driven B-Cell Lymphomas by Targeted Gene Expression Profiling of Fixed Biopsy Specimens
CD Carey, D Gusenleitner, B Chapuy, AE Kovach, MJ Kluk, HH Sun, ...
The Journal of Molecular Diagnostics 17 (1), 19-30, 2015
202015
serum and extracellular Vesicle Micrornas mir-423, mir-199, and mir-93* as Biomarkers for acute graft-versus-host Disease
RE Crossland, J Norden, M Kralj Juric, KF Pearce, C Lendrem, LA Bibby, ...
Frontiers in immunology 8, 1446, 2017
152017
Expression of serum microRNAs is altered during acute graft-versus-host disease
RE Crossland, J Norden, MK Juric, K Green, KF Pearce, C Lendrem, ...
Frontiers in immunology 8, 308, 2017
122017
Tissue-specific expression patterns of microRNA during acute graft-versus-host disease in the rat
D Jalapothu, M Boieri, RE Crossland, P Shah, IA Butt, J Norden, ...
Frontiers in immunology 7, 361, 2016
122016
Genetic association of hematopoietic stem cell transplantation outcome beyond histocompatibility genes
R Gam, P Shah, RE Crossland, J Norden, AM Dickinson, R Dressel
Frontiers in immunology 8, 380, 2017
112017
The automated monocyte count is independently predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of survival following first-line chemotherapy
R Mazumdar, P Evans, R Culpin, J Bailey, D Allsup
Leukemia research 37 (6), 614-618, 2013
112013
B-cell-based and soluble biomarkers in body liquids for predicting acute/chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
MK Juric, M Shevtsov, P Mozes, J Ogonek, RE Crossland, AM Dickinson, ...
Frontiers in immunology 7, 660, 2017
72017
Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study
F Ahmed, S Bakhashab, I Bastaman, R Crossland, M Glanville, J Weaver
International journal of molecular sciences 19 (10), 3242, 2018
42018
Validation of Isolation Methodology and Endogenous Control Selection for qRT-PCR Assessment of Microrna Expression in Serum and Urine Exosomes
RE Crossland, J Norden, L Bibby, J Davis, AM Dickinson
Blood, The Journal of the American Society of Hematology 124 (21), 5793-5793, 2014
22014
Differential Microrna expression levels in cutaneous acute graft-Versus-host Disease
S Atarod, J Norden, LA Bibby, A Janin, P Ratajczak, C Lendrem, ...
Frontiers in immunology 9, 1485, 2018
12018
MICA genotype, serum and expression level effects on the outcome of HSCT
R Gam, J Norden, R Crossland, K Pearce, E Holler, R Dressel, ...
European Cells and Materials 29 (3), 53, 2015
12015
Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease
RE Crossland, J Norden, M Collin, AM Dickinson
Blood, The Journal of the American Society of Hematology 124 (21), 1088-1088, 2014
12014
Mature MicroRNAs Mir-18,-19a,-19b,-17-5p and-92 of the Mir-17-92 Cluster Predict for Treatment Free Survival In Patients with Chronic Lymphocytic Leukaemia
RE Culpin, K Pearce, JR Bailey, NJ Sunter, JC Pointon, SJ Proctor, ...
Blood, The Journal of the American Society of Hematology 116 (21), 2727-2727, 2010
12010
Review of genetic variation as a predictive biomarker for chronic Graft-versus-Host-Disease after allogeneic stem cell transplantation
J Partanen, K Hyvärinen, H Bickeböller, K Bogunia-Kubik, RE Crossland, ...
Front. Immunol. 11: 575492. doi: 10.3389/fimmu, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20